- Medicover
- Platforma Benefitowa
- Endometriosis predisposition assessment - EndomKIT test
Endometriosis predisposition assessment - EndomKIT test
A non-invasive test for women with a suspected diagnosis of endometriosis that is performed on a sample of venous blood taken from the patient.
The price includes all fees
Lowest price from 30 days before discounting PLN 574.75Endometriosis predisposition assessment - EndomKIT test
What is the test about?
In the first part of the test, the levels of biomarkers related to endometriosis will be measured in the patient's blood serum: CA 125 (tumour antigen 125) and BDNF (brain-derived neurotrophic factor).
In the next step, a result is generated on the basis of the patient's clinical data and the measured CA125 and BDNF concentrations using specialised software and a diagnostic algorithm.
What is the objective of the test?
The test is useful for the early detection of endometriosis in patients with suspected endometriosis and symptoms of endometriosis: pelvic pain (such as painful menstruation, ovulation, dyspareunia, painful bowel movements and urination, joint and back pain) and/or infertility. It is a tool to support the diagnosis of endometriosis in combination with other available clinical information.
Treatment can be started earlier if endometriosis is diagnosed early.
Endometriosis affects 5-10% of women of reproductive age and 30-50% of women with endometriosis have experienced infertility.
Test results
The diagnostic accuracy of the test has been determined by comparison with the gold standard in the diagnosis of endometriosis - laparoscopic examination with histopathological confirmation. The test provides a positive or negative result.
In the case of a positive result, the probability of endometriosis is close to 100%. In the case of a negative result, if the reason for the test was infertility, the probability that the patient does not have endometriosis is 85%, and if the reason for the test was pelvic pain, the probability that the patient does not have endometriosis is 65%.
![]() | The diagnostic report and the test result need to be interpreted by the doctor, who will discuss them with the patient and decide on further treatment. |
Additional information about how to get tested at Medicover Centre
- The blood sample for the EndomKIT test is taken in the same way as for other blood tests.
- Before the blood sample is taken, you will need to complete a questionnaire, which is available at the Medicover centre.
![]() | Please note that you should arrive for the test between 7.30 and 9.30 a.m., on an empty stomach, and at least 10 hours after your last meal. |
Others also bought

The diagnosis of endometriosis is usually delayed by about 4 to 8 years. This is mainly due to the difficulty in diagnosing the condition. At Medicover, the disease is diagnosed using ultrasound for deep infiltrating endometriosis with the use of gel contrast (performed through a vaginal probe). The examination takes about 30 minutes and is painless. It is best carried out in the first phase of the cycle after the end of menstruation .

The EndoRNA test is an innovative test that allows you to quickly diagnose endometriosis. A gynaecologist can qualify you for the EndoRNA test with the possibility of performing the test during one visit. There is a short waiting time for results – about 2-3 weeks.

Liquid-based cytology detects about 64% more high-risk lesions than conventional cytology and enables the early detection of human papillomavirus (HPV) infection – the virus that causes cervical cancer. Meanwhile, LBC with HPV-14 genotyping also makes it possible to determine the specific HPV type that can lead to cancer, making it easier to assess risk and increasing the chances of a complete cure.
